Purpose: We docum ented th e resu lts of high energy tra n su re th ra l microwave therm otherapy in th e tre a tm e n t of benign pro static hyperplasia.
Bladder outlet obstruction in men has been a clinical prob lem throughout medical history. As early as the 17th century it was suggested that benign prostatic hyperplasia (BPH) could result in mechanical obstruction of the bladder outlet, which may eventually cause lower urinary tract symptoms, inefficient bladder emptying with poor urinary flow and/or post-micturition residual urine.1 At this juncture the patient usually seeks medical advice either because of troublesome symptoms or complaints secondary to the worsened voiding, for example recurrent urinary tract infections.
Presently, transurethral resection of the prostate is the gold standard therapy for BPH, affording excellent results in the hands of the experienced surgeon. The success of trans urethral resection of the prostate is defined by the immediate removal of obstructing prostatic tissue resulting in the for mation of cavities. Long lasting improvement in symptoms and voiding parameters is achieved within a few days of treatment. However, this operation is not to be taken lightly. Although the mortality rate has decreased to 0.5%,2 the morbidity rate after transurethral resection of the prostate is still 18% and has not altered significantly within the last 15 years. Consequently, despite the proved safety and efficacy of this procedure, its morbidity as well as its relatively high cost and invasive nature have led many investigators to search for an alternative treatment.
Many techniques that minimize the physiological effects associated with prostatic surgery are currently being as sessed, including use of prostatic stents,3 transurethral needle ablation,^ high intensity focused ultrasound,5 trans urethral microwave thermotherapy6 and laser therapy.7 The question as to which technique is appropriate in any individ ual is answered largely by knowing the outcome of each of these therapies. Despite the encouraging results claimed for all of the new techniques, transurethral resection of the Accepted for publication January 26, 1996.
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issu e for w hich category 1 CME credits can be earned. In structions for obtaining credits are given w ith the questions on pages 222 and 223. 97 prostate continues to surpass its competitors. However, the results of high energy thermotherapy seem to shed a new light on this discussion. The results reported with lower energy thermotherapy us ing Prostasoft 2.0* in the treatment of BPH are promising. Overall symptomatic improvement has been reported in the majority of patients in conjunction with improvement of void ing parameters.8-10 The Madsen symptom score decreased from a mean of 13 before treatment to about 4 after treat ment, while mean maximum flow change ranged from 2 to 3 ml. per second. It has been suggested that the placebo re sponse with this modality may contribute considerably to treatment outcome. However, 5 sham controlled studies have demonstrated that the effect of transurethral microwave thermo therapy is greater than can be accounted for by either the associated urethral instrumentation or by any placebo effect.11 The re-treatment rate after transurethral micro wave thermotherapy was reportedly 0.5 to 11% at 1 year of followup.9-10-12
An increase in thermal dose can be seen with the evolution of thermal treatment modalities. The elevation of intrapros tatic temperatures as measured by invasive thermometry during transurethral microwave thermotherapy using ver sion 2.0 operating software has been shown to be broadly correlated with clinical outcome.13 Program version 2.0 was modified to provide more power at a maximum of 70 watts, and uses a higher rectal threshold leading to an increase in the energy delivered to the prostate. This new version of the operating software, known as Prostasoft version 2.5, is cur rently under evaluation. In contrast to earlier reports on results achieved with lower energy thermotherapy, the re sults with these higher energy levels seem to be excellent, and in a subgroup of patients they are even comparable to those of surgical therapy. We present the results of a multi center study using high energy thermo therapy for the treat ment of BPH. Of the patients 67 have reached 1 year of followup, while 105 were followed 26 weeks. Among the 11 patients who were not seen at 26 w eeks 2 died of nontreatm ent related causes (1 of terminal heart failure 4 m onths after treatm ent and 1 of pulmonary failure due to a 1-antitrypsin deficiency), 3 under went transurethral resection of the prostate and 6 were lost to followup. M ean M adsen symptom score at baseline was 13.6, and improved to 9.4 at 4 weeks, 6.0 at 12 w eeks, 5.5 at 26 weeks and 4,9 at 52 weeks of followup ( fig. 1, A) . The I-PSS showed a sim ilar pattern, w ith im provem ent from a m ean of 17.5 at baseline to 13.9 at 4 weeks, 8.2 at 12 w eeks, 7.9 at 26 weeks and 7.1 at 52 w eeks of followup ( fig. 1, B ). M axim um flow rate improved from 9.6 ml. per second at baseline to 9.8 at 4 w eeks, 15.2 at 12 w eeks and 14.1 at 26 w eeks of followup. These im provem ents were sustained to 52 w eeks, with a m aximum flow rate of 14.5 ml. per second ( fig. 1, C) . The voided volume during followup increased slightly ( fig. 2, A) , while the post-void residual decreased significantly from 73 ml. at baseline to 40 ml. at 4 weeks, 27 at 12 w eeks, 33 at 26 w eeks and 25 at 52 w eeks of followup ( fig. 2, B) . Mean duration of transurethral drainage was 14.3 ± 15.2 days (range 0 to 105).
Transrectal ultrasonography at 3 m onths of followup iden tified a cavity in 37% of the patients (fig. 3 ). There appeared to be good statistical correlation betw een the presence of cavities and uroflowmetry im provem ent (p = 0.003). M axi mum flow rate improved from 9.7 ml. per second at baseline to 17.9 ml. per second in patients w ith a cavity on transrectal ultrasound and from 9.6 to 13.6 ml. per second in those w ithout a cavity. Currently, data for 83 patients are available for urodynamic analysis. At 6 m onths after transurethral microwave therm otherapy a statistically significant im prove m ent was noted for all pressure-flow param eters, which is also clearly illustrated in the Abrams-Griffith nomogram ( fig.  4 and table 1) . B aseline param eter stratification versus treatm ent outcome showed that particularly patients w ith larger prostates and moderate to severe bladder outlet ob struction respond best to high energy transurethral micro wave therm otherapy (table 2). These patients showed a sig nificant im provem ent in objective and subjective param eters. pulmonary diseases and high operative risks, a minimally invasive treatment has been sought, including medica tion20» 21 and instrumentation.3"7 With the concept of trans urethral microwave thermotherapy as an outpatient and anesthesia-free procedure, and the encouraging clinical re sults achieved to date, much effort has been concentrated on developing this treatment modality. Application of higher energy levels for thermotherapy us ing Prostasoft 2.5 software was first reported by Devonec6 and de la Rosette11 et al, who demonstrated clinically signif icant improvement. Our present multicenter study confirms these results. The changes in subjective parameters using the high energy Prostasoft 2.5 software is similar to the improvement noted in patients treated with the Prostasoft 2.0 version.6 However, when comparing the objective param eters, a significantly better outcome in terms of urinary peak flow change was noted. A statistically significant increase in maximum flow of 9.6 to 15.2 ml. per second was noted at 12 weeks after transurethral microwave thermotherapy, which was sustained to at least 1 year. Mean post-void residual also improved significantly from 73 to 27 ml. at 12 weeks and 25 ml. at 1 year. This objective improvement in uroflowmetry results was much more pronounced than in patients treated with the lower energy software. Transrectal ultrasound im aging of the prostate identified a cavity in 37% of the patients at 3 months after treatment ( fig. 3) . A positive correlation between the presence of such a cavity and urinary flow rate improvement was observed. One may conclude that more energy delivered to the prostate seems to result in greater improvement in objective parameters, which may be ex plained by the creation of cavities within the prostate. How ever, when such a cavity is absent the treatment should not be regarded as a failure because uroflowmetry may improve independent of cavitjf formation.
The relationship betw een maxim um flow rate at baseline and treatm ent outcome w as much less. There appeared to be no relationship betw een treatm ent outcome and M adsen sym p tom score at baseline. High energy therm otherapy resulted in considerable mor bidity. Irritative voiding com plaints were noted in a large number of patients for up to 2 to 4 w eeks, and transient hem aturia was present in m ost patients during the first days after treatm ent. Finally, retrograde ejaculation w as docu m ented in a third of the patients who had antegrade ejacu lation before treatm ent.
Although uroflowmetry is an excellent method to document the act of micturition, and it may indicate whether an abnor mality is present, its role in defining the grade of obstruction is limited. 22 For transurethral microwave thermotherapy to be regarded as proper therapy for BPH, it must be able to relieve the outlet obstruction. Advanced urodynamics, in cluding pres sure-flow study analysis, are considered the best methods to document changes in the grade of obstruction. 22 The changes in pressure-flow study parameters were only moderate with the lower energy Prostasoft 2.0 software. We concluded that only a certain type of obstruction responded favorably to thermotherapy.23 '24 In general, however, severe obstruction is not cured following low energy thermo therapy.
Analysis of the urodynamic data at 6 months after transure thral microwave thermotherapy using Prostasoft 2.5 showed that 80% of obstruction patients appeared to be cured (fig, 4) . A significant decrease in all obstruction parameters was noted overall (table 1), One can conclude that transurethral microwave thermotherapy using Prostasoft version 2.5 is able to relieve bladder outlet obstruction.
From an earlier study we learned that no single clinical parameter could predict which patients would respond best to low energy thermotherapy.25 Using high energy thermo therapy it appears that patients with more severe outlet obstruction and larger prostates will respond best. Further studies are required to explain this phenomenon. A possible explanation for the favorable outcome of treatm ent of larger prostates is a difference in tissue composition and tissue perfusion. It is well known that stromal tissue responds differently to heat than glandular tissue.26 Larger prostates may have a different distribution of stromal and glandular tissue, and consequently they may respond differently to thermotherapy. We also know that the temperature increase in the prostate depends strongly on the tissue perfusion, and that perfusion is known to increase with temperature during thermotherapy.27> 28 One can speculate that in larger pros tates the tissue perfusion is less efficient than in smaller prostates, and that perhaps as a consequence higher temper atures can be achieved resulting in necrosis with formation of a cavity. Current thermotherapy systems do not consider the effect of tissue perfusion on the efficacy of the treatment.
Although urine flow is improved, the morbidity caused by high energy transurethral microwave thermotherapy is in creased compared to lower energy protocols. The high energy treatment is well tolerated by the patients but pain medica tion must be administered before or during therapy in most cases. On a trial and error basis, 30 mg. morphine sulfate administered 2 hours before therapy resulted in an almost complaint-free treatment. If requested, patients also were given either 10 mg. diazepam and/or 0,10 mg, fentanyl dur ing treatment. Perception of discomfort during transurethral microwave thermotherapy may vary from a mild sensation of perineal warmth and a mild urge to urinate to significant discomfort. However, the morbidity is clearly lower with transurethral microwave thermotherapy than with transure thral resection of the prostate. Transurethral microwave thermotherapy can still be performed as an outpatient pro cedure without general anesthesia, and it is particularly well suited for patients in poor health. Occasionally, hematuria and tissue slough are noted, and urinary retention is ex prostates required longer catheterization periods than those with smaller prostates. The finding of retrograde ejaculation in a third of our patients is in contrast to those documented with lower energy thermotherapy, in which antegrade ejac ulation was unchanged in the majority of patients. 29 No bladder neck contraction or urethral strictures have been noted to date. Treatment was repeated in 3 patients because they were not satisfied with the result. From the long-term foliowup data using Prostasoft 2.0 we have learned that the re-treatment rate at 1 year is estimated up to 10%,30 while 3-year followup data by de Wildt and de la Rosette,27 and Dahlstrand et al31 indicate that clinical benefit is sus tained for this period. One may expect that the results achieved with the higher energy software are at least as good.
In conclusion, high energy transurethral microwave ther motherapy shows significant subjective and objective im provement. The best candidates are patients with moderate to severe bladder outlet obstruction and larger prostates. Formation of cavities after treatment correlated well with better clinical outcome.
